Wearable Injectors and Connected Devices USA Conference 2024

September 9-10, 2024 - Boston, MA, United States

We are proud to announce the 2nd Annual Wearable Injectors and Connected Devices USA Conference taking place on the 9th and 10th of September 2024.

As the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows, on-body injectors and connected devices hold great opportunity. The conference will delve into on-body device design and development, latest advances in connectivity and digital integration of wearable devices, and opportunities for enhancement of user-interface through human factors case studies. The conference will also address challenges in regulations surrounding wearable injectors and connected devices with case studies and an FDA keynote on cybersecurity.

As part of our leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in September 2024!

Why to attend:

  • 2 full days of networking opportunities.
  • 16+ sessions with 75% of speakers from big pharma companies
  • An agenda designed for professionals within the wearable injectors space, focused on the development, implementation and application of wearable injectors and connected devices.
  • The only conference discussing wearable injectors and connected devices together.

The experience:

  • A collaborative environment for pharma, biotech and device developers to discuss the latest trends and challenges within the wearable injectors and connected device market.
  • Learn from key industry players about new technologies, strategies and processes for the development of wearable injectors.
  • Gain insights into the regulatory processes for the approval of wearable injectors and develop a greater understanding of how-to bring devices to market.
  • Create a dialogue with industry leaders for wearable injectors, and develop a network with the key stake-holders in the market.
  • Delve into the world of digital health and connectivity for the healthcare sector, and discuss the future of connectivity for wearables.
  • Examine the importance of usability for at home injectors, and what is needed to make a device appropriate for patient administration.

Who should attend:

Directors, Heads of Departments and Managers in the following areas:
  • Device Development
  • Smart Devices
  • Digital Health and Connectivity
  • Connected Devices
  • Device Engineering
  • Drug Delivery
  • Formulation for Wearables
  • Combination Product Development
  • On Body Device Development
  • Large Volume Drug Delivery
  • Regulatory Affairs
  • Medical Devices
Our Wearable Injectors and Connected Devices event is the only conference that discusses both wearable injectors and connected devices in one event. Over two days, we bring together executives within the pharmaceutical industry to discuss the opportunities and challenges that face on-body devices, and to collaborate on the future of the industry. The event provides and intimate environment to speak with experts and peers to learn from each other’s experiences, and to meet with a variety of solutions providers working to supplement the industry.

Taking place at the end of the week at the same venue:

Continue your networking through the week at PFS Connect which takes place in the same venue, the following day

Featured Speakers

  • Ajit D'Souza, Senior Director, Combination Product Development & Manufacturing,Kiniksa Pharmaceuticals
  • Deep S Bhattacharya, Principal Scientist, Formulation and Process Development - Biotherapeutics, Pfizer
  • Jamie Tsung, Head of DP Formulation, CMC, Alnylam
  • Karen Lowitz, Associate Director, Regulatory CMC Devices & Combination Product, Biogen
  • Liem Nguyen, Associate Principle Scientist- Device Program Lead, Merck
  • Ling Zheng, Director - Device Development, Alexion Pharmaceuticals Inc
  • Martin McLoughlin, Head of Device Development, Bristol Myers Squibb
  • Matt Marber, Senior Usability Engineer, Novo Nordisk
  • Paul Upham, Global Head of Smart Devices, Roche-Genentech
  • Peter Petrochenko, Associate Director, Regulatory Strategy, Regeneron Pharmaceuticals
  • Samir Shah, Director, Regulatory CMC, Devices and Therapeutics, AstraZeneca
  • Stephen Gianelis, Senior Director, Digital Health Operations, Teva Pharmaceuticals
  • Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis
  • Theresa Scheuble, Head of Design & Innovation, Johnson & Johnson

Please fill in your name and email to receive the Conference Agenda of this event.


Courtyard by Marriott Boston Downtown
275 Tremont St, 02116
Boston, MA, USA